Back to 
SUSQUEHANNA INTERNATIONAL GROUP, LLP
SUSQUEHANNA INTERNATIONAL GROUP, LLP
SABS1 quarters
Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in SAB BIOTHERAPEUTICS INC
Yes. Susquehanna International Group holds 438,515 shares of SABS (Sab Biotherapeutics), worth $1.7M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$1.7M
Current Shares
438,515
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.